In this feature article #RobBrown highlights how the approval of #teplizumab could be “the biggest breakthrough since the discovery of insulin” in #diabetes treatment and researchers hope it could lead to a “functional cure”

#ukpharmacy #immunotherapy

buff.ly/wQEGsWe

New per-protocol results from the PROTECT trial show that teplizumab helps preserve beta cell function and supports better glucose management in children and adolescents newly diagnosed with stage 3 type 1 diabetes. #T1D #teplizumab #diabetesmanagement link.springer.com/article/10.1... 🔓